drugset / Trial / NCT00239460

Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD

NCT00239460

Phase 3 Completed 196 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to evaluate the effect of inhaled tiotropium bromide on trough FEV1 and to assess the cardiac effects through 12-lead and Holter ECG monitoring in patients with COPD.

Timeline

Start
2003-07
Primary completion
2004-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified Inhaled